Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (BMRN) Stock Overview

Explore BioMarin Pharmaceutical Inc.’s financial performance, market position, analyst ratings, and future outlook.

BMRN●NASDAQ
HealthcareBiotechnology
$60.20
$0.21(0.34%)
U.S. Market is Open · 14:24

BioMarin Pharmaceutical Inc. (BMRN)

Meyka AI Score

Z

Key Financials

Market Cap11.7B
P/E Ratio43.15
EPS (TTM)$2.08
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$57.19
3 Months$52.62
1 Year Target$53.88

BMRN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, BioMarin Pharmaceutical Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BMRN on the NASDAQ shows an RSI of 57.37, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $53.88 for the NASDAQ listing.

Key metrics behind BioMarin Pharmaceutical Inc.'s NASDAQ-traded stock include a P/E ratio of 43.15 and a market capitalization of 11.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BMRN on the NASDAQ.

Price Performance (NASDAQ: BMRN)

1-Day Change
1.21%
5-Day Change
0.20%
1-Month Change
3.28%
3-Month Change
9.48%
6-Month Change
5.38%
Year-to-Date (YTD) Change
2.17%
1-Year Change
0.68%
3-Year Change
-31.42%
5-Year Change
-20.57%
All-Time (Max) Change
362.45%

Contact Information

https://www.biomarin.com
415 506 6700
770 Lindaro Street, San Rafael, CA, 94901

Company Facts

32,210 Employees
IPO DateJul 26, 1999
CountryUS
Actively Trading

Frequently Asked Questions